The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
about
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives.Carcinoid-syndrome: recent advances, current status and controversies.18-Fluoride labeled sodium fluoride positron emission tomography with computer tomography: the impact of pretreatment staging in intermediate- and high-risk prostate cancer.Molecular Imaging in Oncology Using Positron Emission Tomography.Neuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Impact of Somatostatin Rec ...... atic Review and Meta-Analysis.
@en
The Impact of Somatostatin Rec ...... atic Review and Meta-Analysis.
@nl
type
label
The Impact of Somatostatin Rec ...... atic Review and Meta-Analysis.
@en
The Impact of Somatostatin Rec ...... atic Review and Meta-Analysis.
@nl
prefLabel
The Impact of Somatostatin Rec ...... atic Review and Meta-Analysis.
@en
The Impact of Somatostatin Rec ...... atic Review and Meta-Analysis.
@nl
P2093
P1476
The Impact of Somatostatin Rec ...... matic Review and Meta-Analysis
@en
P2093
Johannes Czernin
Ken Herrmann
Martin Barrio
Matthias Eiber
Valentina Ambrosini
Wolfgang P Fendler
P304
P356
10.2967/JNUMED.116.185587
P407
P577
2017-01-12T00:00:00Z